Causal relationships between blood metabolites and glioblastoma risk: a large-scale Mendelian randomization study

This study represents the first large-scale Mendelian randomization analysis to establish causal relationships between multiple blood metabolites and glioblastoma risk, particularly identifying protective factors within phospholipid and tryptophan metabolic pathways.